Filters

Dai Maruyama, Hirokazu Nagai, Yoshinobu Maeda, Takahiko Nakane, Tatsu Shimoyama, Tomonori Nakazato, Rika Sakai, Takayuki Ishikawa, Koji Izutsu, Ryuzo Ueda, Kensei Tobinai

Cancer science 2017;108(10):2061-2068

Free Full Text

Abstract

Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.

Chin-Lun Huang, Zhong-Zhe Lin, Ih-Jen Su, Tsu-Yi Chao, Hwei-Fang Tien, Ming-Chih Chang, Ming-Che Huang, Woei-Yau Kao, Jih-Luh Tang, Kun-Heui Yeh, Chiu-Hwa Wang, Chih-Hung Hsu, Mei-Yin Liu, Ann-Lii Cheng

Leukemia & lymphoma 2003;43(7):1415-20

Full Text

Abstract

Targeted molecular therapy in peripheral T-cell lymphomas.

Pier Luigi Zinzani, Pier Paolo Piccaluga, Stefano A Pileri, Fernando Roncolato, Anna Gazzola

Expert review of hematology 2012;4(5):551-62

Full Text

Abstract

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.

Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae, Dong Hwan Kim, Jin Ho Baek, Kyu Bo Lee, Je-Jung Lee, Ik-Joo Chung, Hyeoung-Joon Kim, Deok-Hwan Yang, Won-Sik Lee, Young-Don Joo, Chang-Hak Sohn

Cancer chemotherapy and pharmacology 2006;58(1):35-9

Full Text

Abstract

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.

Takayuki Ishikawa, Hidetsugu Kawai, Kiyoshi Ando, Dai Maruyama, Kazuhito Yamamoto, Eiji Kiyohara, Yasuhito Terui, Noriko Fukuhara, Tomomitsu Miyagaki, Yoshiki Tokura, Mamiko Sakata-Yanagimoto, Tadahiko Igarashi, Junya Kuroda, Jiro Fujita, Toshiki Uchida, Kentaro Yonekura, Koji Kato, Tadashi Nakanishi, Kenya Nakai, Risa Matsunaga, Kensei Tobinai

Cancer science 2021;112(6):2426-2435

Free Full Text

Abstract

Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.

Serdar Altınay, Alev Kural, Aykut Özmen, Deniz Tural, Yusuf Tutar

Anti-cancer agents in medicinal chemistry 2023;23(3):298-305

Full Text

Abstract

Results: 1 – 15 / 24

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Lymphoma, T-Cell, Peripheral""[mesh_terms]

Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Pralatrexate injection combined with CHOP for treatment of PTCL: results from the Fol-CHOP dose-finding phase 1 trial.

X. Challenges and future directions in peripheral T-cell lymphoma.

Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine.

Novel therapies in peripheral T-cell lymphomas.

Pralatrexate: a comprehensive update on pharmacology, clinical activity and strategies to optimize use.

Treatment strategies for peripheral T-cell lymphomas.

Exploring the Anti-Leukemic Effect of the Synthetic Retinoid ST1926 on Malignant T Cells: A Comprehensive Proteomics Approach.

Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study.

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphoma.

Combination of 13-cis retinoic acid and interferon-alpha in the treatment of recurrent or refractory peripheral T-cell lymphoma.

Targeted molecular therapy in peripheral T-cell lymphomas.

CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas.

Phase II study of E7777 in Japanese patients with relapsed/refractory peripheral and cutaneous T-cell lymphoma.

Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind.

Results for
""Lymphoma, T-Cell, Peripheral""[mesh_terms]